Catalyst Pharmaceutical
CPRX
CPRX
259 hedge funds and large institutions have $1.47B invested in Catalyst Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 93 increasing their positions, 84 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
259
Holders Change
+2
Holders Change %
+0.78%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
47
Increased
93
Reduced
84
Closed
43
Calls
$43M
Puts
$1.76M
Net Calls
+$41.3M
Net Calls Change
+$36.3M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$74.1M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$22.8M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$18.2M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.52M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.36M |
Top Sellers
| 1 |
Man Group
London,
United Kingdom
|
-$16.5M |
| 2 |
Millennium Management
New York
|
-$15.9M |
| 3 |
Two Sigma Investments
New York
|
-$12.3M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$11M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.37M |
